Company News Summary

ResMed Announces Record Financial Results for 4Q12 Fiscal Year End

Original announcement: Record Financial Results for 4Q12 & Fiscal Year-End

ResMed announced record revenue and income for the quarter ended 30 June 2012. Revenue for the quarter was $371.9m, a 9% increase (a 13% increase on a constant currency basis) over the quarter ended 30 June 2011. Net income for the quarter was $76.8m, an increase of 31% compared to the quarter ended 30 June 2011. Diluted EPS for the quarter were $0.53, an increase of 43% compared to the prior corresponding period (pcp). For the year ended 30 June 2012, revenue was $1.37bn, an increase of 10% over the year ended 30 June 2011 (11% increase on a constant currency basis). Net income for the year was $254.9m, an increase of 12% compared to the pcp. Diluted EPS for the year were $1.71, an increase of 19% compared to the pcp. The board has also declared a quarterly dividend of $0.17 per share, with a record date of 7 September 2012 and a payment date of 28 September 2012.

Please click here for full details

See more ASX300 News Announcements